| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | -0.0024 | 1 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | -0.01 | 1 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | 0.0025 | 1 |
| mRNA | Vorinostat | FIMM | pan-cancer | AAC | -0.0073 | 1 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | 0.0011 | 1 |